Cargando…

Novel brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer’s disease and mild cognitive impairment

Alzheimer’s disease (AD) is a devastating neurodegenerative disease with a concealed onset and continuous deterioration. Mild cognitive impairment (MCI) is the prodromal stage of AD. Molecule-based imaging with positron emission tomography (PET) is critical in tracking pathophysiological changes amo...

Descripción completa

Detalles Bibliográficos
Autor principal:	Huang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537554/ https://www.ncbi.nlm.nih.gov/pubmed/36211392 http://dx.doi.org/10.3389/fimmu.2022.1010946

Ejemplares similares

PET Imaging of Neuroinflammation in Alzheimer’s Disease
por: Zhou, Rong, et al.
Publicado: (2021)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013)

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2008)

The Association Between Acquired Color Deficiency and PET Imaging of Neurodegeneration in Mild Cognitive Impairment and Alzheimer Disease
por: Vidal, Kallene Summer Moreira, et al.
Publicado: (2022)

Diffusion Tensor Imaging in Alzheimer’s Disease and Mild Cognitive Impairment
por: Stebbins, G. T., et al.
Publicado: (2009)

Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2018)

Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer’s disease in mild cognitive impairment patients
por: Qian, Xiao-hang, et al.
Publicado: (2022)

Quantitative (18)F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients
por: Zhao, Qian, et al.
Publicado: (2019)

In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease
por: Low, Audrey, et al.
Publicado: (2021)

Brain Representation of Animal and Non-Animal Images in Patients with Mild Cognitive Impairment and Alzheimer’s Disease
por: Marefat, Haniyeh, et al.
Publicado: (2023)

Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2017)

[(18)F]THK5351 PET Imaging in Patients with Mild Cognitive Impairment
por: Jeong, Hye Jin, et al.
Publicado: (2020)

Methylprednisolone alleviates cognitive functions through the regulation of neuroinflammation in Alzheimer’s disease
por: Sun, Yuan, et al.
Publicado: (2023)

Evaluation of Imaging Windows for Tau PET Imaging Using (18)F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
por: Chotipanich, Chanisa, et al.
Publicado: (2020)

Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease
por: De Felice, Fernanda G., et al.
Publicado: (2015)

Structural brain imaging in Alzheimer’s disease and mild cognitive impairment: biomarker analysis and shared morphometry database
por: Ledig, Christian, et al.
Publicado: (2018)

Corneal Nerve and Brain Imaging in Mild Cognitive Impairment and Dementia
por: Al-Janahi, Eiman, et al.
Publicado: (2020)

Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer’s Disease
por: Liu, Yuqing, et al.
Publicado: (2022)

Structural MRI and Amyloid PET Imaging for Prediction of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis
por: Seo, Eun Hyun, et al.
Publicado: (2017)

(18)F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
por: Chang, Yan, et al.
Publicado: (2020)

Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment
por: Clark, David Glenn, et al.
Publicado: (2016)

Brain-Specific Increase in Leukotriene Signaling Accompanies Chronic Neuroinflammation and Cognitive Impairment in a Model of Gulf War Illness
por: Attaluri, Sahithi, et al.
Publicado: (2022)

Radiomics: a novel feature extraction method for brain neuron degeneration disease using (18)F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment
por: Li, Yupeng, et al.
Publicado: (2019)

Brain Connectivity Based Prediction of Alzheimer’s Disease in Patients With Mild Cognitive Impairment Based on Multi-Modal Images
por: Zheng, Weihao, et al.
Publicado: (2019)

Structural Brain Imaging Phenotypes of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Found by Hierarchical Clustering
por: Kärkkäinen, Mikko, et al.
Publicado: (2020)

Comparison of brain microstructure alterations on diffusion kurtosis imaging among Alzheimer’s disease, mild cognitive impairment, and cognitively normal individuals
por: Chu, Xiaoqi, et al.
Publicado: (2022)

Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients
por: Le Page, Aurélie, et al.
Publicado: (2017)

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images
por: Shen, Ting, et al.
Publicado: (2019)

Imaging blood–brain barrier disruption in neuroinflammation and Alzheimer’s disease
por: Lee, Rae-Ling, et al.
Publicado: (2023)

Deep-Learning Radiomics for Discrimination Conversion of Alzheimer's Disease in Patients With Mild Cognitive Impairment: A Study Based on (18)F-FDG PET Imaging
por: Zhou, Ping, et al.
Publicado: (2021)

The Alzheimer’s disease metabolic brain pattern in mild cognitive impairment
por: Meles, Sanne K, et al.
Publicado: (2017)

Diverse proteins aggregate in mild cognitive impairment and Alzheimer’s disease brain
por: Kepchia, Devin, et al.
Publicado: (2020)

Association of imaging abnormalities of the subcallosal septal area with Alzheimer's disease and mild cognitive impairment
por: Gan, C.L., et al.
Publicado: (2017)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
por: Jiao, Fangyang, et al.
Publicado: (2023)

N-docosahexaenoylethanolamine reduces neuroinflammation and cognitive impairment after mild traumatic brain injury in rats
por: Ponomarenko, Arina I., et al.
Publicado: (2021)

The effects of microglia-associated neuroinflammation on Alzheimer’s disease
por: Wang, Cuicui, et al.
Publicado: (2023)

Regional Magnetic Resonance Imaging Measures for Multivariate Analysis in Alzheimer’s Disease and Mild Cognitive Impairment
por: Westman, Eric, et al.
Publicado: (2012)

Wnt/TLR Dialog in Neuroinflammation, Relevance in Alzheimer’s Disease
por: Zolezzi, Juan M., et al.
Publicado: (2017)

Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging
por: Cerami, Chiara, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6u7hhi7927m12tp1q9fjgekslo